- Home
- Publications
- Publication Search
- Publication Details
Title
Traditional and New Influenza Vaccines
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 26, Issue 3, Pages 476-492
Publisher
American Society for Microbiology
Online
2013-07-04
DOI
10.1128/cmr.00097-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cardiovascular manifestations of influenza: A systematic review
- (2013) Zahra Raisi Estabragh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey
- (2012) Roman Prymula et al. ADVANCES IN THERAPY
- Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010–2011 influenza season
- (2012) Patrick A. Dhont et al. ADVANCES IN THERAPY
- Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
- (2012) Stuart M. Levitz et al. CELL
- Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
- (2012) J. E. Ledgerwood et al. Clinical and Vaccine Immunology
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
- (2012) E. Caproni et al. JOURNAL OF IMMUNOLOGY
- Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-Infected Adults: A Randomized Clinical Trial
- (2012) Hana M. El Sahly et al. JOURNAL OF INFECTIOUS DISEASES
- Sometimes, More Is Better
- (2012) E. T. Overton JOURNAL OF INFECTIOUS DISEASES
- A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus
- (2012) J. A. B. Babon et al. JOURNAL OF VIROLOGY
- Recombinant Parainfluenza Virus 5 Vaccine Encoding the Influenza Virus Hemagglutinin Protects against H5N1 Highly Pathogenic Avian Influenza Virus Infection following Intranasal or Intramuscular Vaccination of BALB/c Mice
- (2012) A. J. Mooney et al. JOURNAL OF VIROLOGY
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
- (2012) Fatimah S Dawood et al. LANCET INFECTIOUS DISEASES
- DNA Vaccination in the Skin Using Microneedles Improves Protection Against Influenza
- (2012) Jae-Min Song et al. MOLECULAR THERAPY
- Cross-neutralization of influenza A viruses mediated by a single antibody loop
- (2012) Damian C. Ekiert et al. NATURE
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
- (2012) Masaki Imai et al. NATURE
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
- (2012) Hanna Nohynek et al. PLoS One
- A distinct lineage of influenza A virus from bats
- (2012) S. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- Recombinant protein vaccines produced in insect cells
- (2012) Manon M.J. Cox VACCINE
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
- (2012) Carrie Reed et al. VACCINE
- Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]
- (2012) Christian Savard et al. VACCINE
- Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial
- (2012) Olga Pleguezuelos et al. VACCINE
- Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model
- (2012) Xuefei Shen et al. VACCINE
- Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration
- (2012) Aalzen de Haan et al. VACCINE
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
- (2012) David P. Greenberg et al. VACCINE
- Virus-like particle (VLP)-based vaccines for pandemic influenza
- (2012) Constantino López-Macías Human Vaccines & Immunotherapeutics
- Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina
- (2011) Peter Eizenberg et al. ADVANCES IN THERAPY
- Structural basis of influenza virus neutralization
- (2011) Thomas Han et al. Annals of the New York Academy of Sciences
- Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine
- (2011) Hee Jin Cheong et al. Clinical and Vaccine Immunology
- Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
- (2011) J. Sui et al. CLINICAL INFECTIOUS DISEASES
- Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
- (2011) Paolo Durando et al. Human vaccines & immunotherapeutics
- Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations
- (2011) Angelika Banzhoff et al. Human vaccines & immunotherapeutics
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
- (2011) Jens Wrammert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
- (2011) I. Jelinek et al. JOURNAL OF IMMUNOLOGY
- Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5
- (2011) N. Ohshima et al. JOURNAL OF VIROLOGY
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
- (2011) Harish Nair et al. LANCET
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
- (2011) Timo Vesikari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influenza A/H1N1 MF59-Adjuvanted Vaccine in Preterm and Term Children Aged 6 to 23 Months
- (2011) S. Esposito et al. PEDIATRICS
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
- (2011) Constantino López-Macías et al. VACCINE
- Pandemrix°, (H1N1)v influenza and reported cases of narcolepsy
- (2011) Jean-Louis Montastruc et al. VACCINE
- A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus
- (2011) Dubravka Grdic Eliasson et al. VACCINE
- Safety of pandemic H1N1 vaccines in children and adolescents
- (2011) Leonoor Wijnans et al. VACCINE
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- A systematic review of intradermal influenza vaccines
- (2011) Flora Young et al. VACCINE
- Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes
- (2011) Peter Pushko et al. VACCINE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age☆
- (2011) R. Baxter et al. VACCINE
- Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial
- (2011) John J. Treanor et al. VACCINE
- Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
- (2011) Timo Vesikari et al. VACCINE
- Influenza virus assembly and budding
- (2011) Jeremy S. Rossman et al. VIROLOGY
- Novel vaccines against influenza viruses
- (2011) S.M. Kang et al. VIRUS RESEARCH
- Immune responses to influenza virus infection
- (2011) J.H.C.M. Kreijtz et al. VIRUS RESEARCH
- Heightened neurologic complications in children with pandemic H1N1 influenza
- (2010) Jeffrey J. Ekstrand et al. ANNALS OF NEUROLOGY
- MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
- (2010) Yvonne Genzel et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
- (2010) Jeffery K. Taubenberger et al. Cell Host & Microbe
- Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
- (2010) Vincenzo Baldo et al. Clinical & Developmental Immunology
- A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly
- (2010) E. Fragapane et al. Clinical and Vaccine Immunology
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
- (2010) Davide Corti et al. JOURNAL OF CLINICAL INVESTIGATION
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Molecular Characterization of In Vivo Adjuvant Activity in Ferrets Vaccinated against Influenza Virus
- (2010) Y. Fang et al. JOURNAL OF VIROLOGY
- Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell Responses to 2009 Pandemic H1N1 Swine-Origin Influenza A Virus
- (2010) X. Ge et al. JOURNAL OF VIROLOGY
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
- (2010) T. T. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
- (2010) G. Bommakanti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasomes as mediators of immunity against influenza virus
- (2010) Iris K. Pang et al. TRENDS IN IMMUNOLOGY
- The need for quadrivalent vaccine against seasonal influenza
- (2010) Robert B. Belshe VACCINE
- Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
- (2010) Larry R. Smith et al. VACCINE
- Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence
- (2010) Joon Young Song et al. VACCINE
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
- (2010) Taia T. Wang et al. PLoS Pathogens
- Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
- (2009) Agnieszka Szymczakiewicz‐Multanowska et al. JOURNAL OF INFECTIOUS DISEASES
- Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity
- (2009) Keith S. Reisinger et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older
- (2009) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
- A One-Plasmid System To Generate Influenza Virus in Cultured Chicken Cells for Potential Use in Influenza Vaccine
- (2009) X. Zhang et al. JOURNAL OF VIROLOGY
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
- (2009) Arnold S. Monto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
- (2009) Tristan W. Clark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of the 2004-2005 Influenza Vaccine Shortage on Pediatric Practice: A National Survey
- (2009) L. McQuillan et al. PEDIATRICS
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2009) Angelika Banzhoff et al. PLoS One
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HLA class I molecules consistently present internal influenza epitopes
- (2009) A. Wahl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1)
- (2009) Shi-gui Yang et al. VACCINE
- Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
- (2009) J.H.C.M. Kreijtz et al. VACCINE
- Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months
- (2009) James C. King et al. VACCINE
- Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study
- (2009) Robert Arnou et al. VACCINE
- Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
- (2009) Ruth A. Karron et al. VACCINE
- A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
- (2009) Rebecca J. Cox et al. VACCINE
- Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages
- (2009) B. Camilloni et al. VACCINE
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
- DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial
- (2009) Suzanne Jones et al. VACCINE
- Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season
- (2009) Ian G. Barr et al. VACCINE
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
- (2008) Fabrice Carrat et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Cell-Based Influenza Vaccines
- (2008) Jennifer M Audsley et al. DRUGS
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial
- (2008) David Holland et al. JOURNAL OF INFECTIOUS DISEASES
- Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells
- (2008) S. Murakami et al. JOURNAL OF VIROLOGY
- Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans
- (2008) E. Assarsson et al. JOURNAL OF VIROLOGY
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
- (2008) A. K. Kashyap et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection
- (2008) David S.-C. HUI RESPIROLOGY
- Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
- (2008) Filippo Ansaldi et al. VACCINE
- Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials
- (2008) Janelle Rhorer et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now